Altria Group: Focus on Oral Tobacco Products and Growth

Dec.01.2022
Altria Group: Focus on Oral Tobacco Products and Growth
Altria Group's focus on oral tobacco products leads to expected growth in adjusted earnings per share by 4.5-6%.

US tobacco company Altria Group, Inc. (MO) appears well-prepared to tackle rising costs and weak cigarette sales by focusing on oral tobacco products, thanks to its strong pricing power. The company is expecting adjusted earnings per share between $4.81 and $4.89 in 2022, a growth of 4.5-6% compared to $4.61 in 2021.


Let's delve deeper and take a closer look.


Factors supporting Altria


Due to the serious health risks associated with smoking, consumers are turning to products with reduced risk or no smoke. Altria has been adapting to the changing market by offering a variety of oral, electronic, and heated tobacco products. Altria, through its subsidiary Helix Innovations, owns on!, a popular tobacco-derived nicotine (TDN) pouch product. Management believes that on! is worth mentioning as part of Altria's smoke-free product portfolio as oral TDN products are becoming more popular in the US due to their low-risk claims. In the third quarter of 2022, the net revenue of the oral tobacco products segment increased by 7% compared to the same period last year to $665 million due to price increases. The domestic shipment volume of this segment increased by 1.3%, mainly due to changes in trade inventory, industry growth rate, and calendar differences, with reported shipping volume soaring by about 70%. Additionally, the retail market share of oral tobacco increased compared to the previous quarter, reaching 5.2 share points in the third quarter.


Altria Group surprises with price, consensus, and earnings per share.


Tobacco giant Altria has remained strong thanks to its powerful pricing ability, even during periods of weak cigarette shipments and increased taxes. While higher prices may lead to decreased cigarette consumption, it appears that due to the addictive nature of cigarettes, smokers are willing to accept price hikes. In Q3 of 2022, higher pricing supported revenue in Altria's smokeable and oral tobacco product segments. Additionally, higher pricing helped the adjusted operating company income for both segments. This trend may continue to have room for growth.


Barrier or obstacle.


Cost inflation and rising natural gas prices were unfavorable factors in the third quarter. Additionally, wage costs increased. The continued presence of these factors remains a concern. Management's outlook for 2022 takes into account planned investments related to costs aimed at improving the digital consumer engagement system, strengthening research, development, and regulatory readiness costs for smokeless products, and supporting marketing activities for the company's smokeless products. The outlook also includes expectations for inflation in settlement agreement costs, as well as direct and indirect material costs. In the third quarter of 2022, Altria's net income decreased by 3.5% year-on-year to $6.55 billion, due to lower revenue from the wine segment divestment in October 2021 and decreased revenue from the combustible products segment. Excluding excise taxes, revenue decreased by 2.2% to $5.412 billion.


In the field of smoking products, net income decreased by 1.6% year-on-year to $5.882 billion due to decreased shipments and increased promotional investments. Domestic cigarette shipments fell by 9.2% year-on-year, primarily driven by industry decline and losses in retail market share. However, changes in trade inventory partially offset this impact. After adjusting for changes in trade inventory and other factors, estimates indicate that domestic cigarette shipments for smoking products decreased by 8%.


Bottom line


Overall, cigarette sales have been impacted by increased consumer health awareness and regulatory barriers. However, according to a third quarter earnings call with management, research suggests that despite price increases in the tobacco category compared to other categories, tobacco consumers are more likely to continue purchasing their preferred brands. Pricing power and advantages with smokeless tobacco products may keep Altria on a growth trajectory. The stock price of this third-ranked (hold) Zacks company has risen 1.5% over the past three months, compared to the industry's 1% increase.


2FIRSTS will continue to cover this topic, with updates available on the "2FIRSTS APP". Scan the QR code below to download the app.


This document has been generated through artificial intelligence translation and is provided solely for the purposes of industry discourse and learning. Please note that the intellectual property rights of the content belong to the original media source or author. Owing to certain limitations in the translation process, there may be discrepancies between the translated text and the original content. We recommend referring to the original source for complete accuracy. In case of any inaccuracies, we invite you to reach out to us with corrections. If you believe any content has infringed upon your rights, please contact us immediately for its removal.

World Tobacco Development Report 2024 (Part II)
World Tobacco Development Report 2024 (Part II)
In 2024, global flue-cured tobacco production outside mainland China reached 37.28 million bales, as climate issues led to supply shortages. Prices continued to rise amid currency fluctuations and inflation. ETN highlights trends in the four major producing countries.
May.16 by 2FIRSTS.ai
PMI Brazil CEO Urges Policy Rethink, Backs Smoke-Free Alternatives Like IQOS and Zyn
PMI Brazil CEO Urges Policy Rethink, Backs Smoke-Free Alternatives Like IQOS and Zyn
Branko Svarcic, CEO of Philip Morris Brazil, says the country should rethink its public health approach, especially on e-cigarettes and heated tobacco. While Brazil has banned e-cigarettes since 2009, products like IQOS and Zyn are seen as harm-reduction tools in many countries. He urged the government to learn from global examples and update its policies.
May.26 by 2FIRSTS.ai
Exclusive Interview with UK Brand PIXL: Disposable Ban Sparks “Pod System Opportunity” — High-Puff Refillable Vapes Become the New Must-Have
Exclusive Interview with UK Brand PIXL: Disposable Ban Sparks “Pod System Opportunity” — High-Puff Refillable Vapes Become the New Must-Have
Following the UK’s disposable vape ban, the market saw major shifts. PIXL quickly entered with a “2+10ml” high-puff pod system. At the Dubai expo, the brand highlighted its user-focused design, modular strategy, and noted how the ban is driving demand for compliant refillable products.
Jun.26 by 2FIRSTS.ai
KT&G Shifts HTP Production to Malaysia, 'lil Hybrid 3.0' Supply Normalizes
KT&G Shifts HTP Production to Malaysia, 'lil Hybrid 3.0' Supply Normalizes
South Korea's KT&G has moved its production of the "lil Hybrid 3.0" heated tobacco device from Vietnam to Malaysia, responding to Vietnam's impending ban on e-cigarettes and heated tobacco products. The relocation has resolved prior supply disruptions, with normal distribution resuming earlier this month. KT&G's "lil" series currently holds approximately 45.8% of South Korea's heated tobacco market, maintaining a lead over PMI.
May.09 by 2FIRSTS.ai
South Korean Social Organizations Support Lawsuits Against Tobacco Companies and Call for the Establishment of a Smoking Damage Fund
South Korean Social Organizations Support Lawsuits Against Tobacco Companies and Call for the Establishment of a Smoking Damage Fund
The Korea Association of the Elderly Strongly Backs the National Health Insurance Corporation’s Tobacco Litigation, Calling on Tobacco Companies to Establish a Smoking Damage Fund to Fulfill Their Social Responsibilities.
Jun.11 by 2FIRSTS.ai
Malaysia’s Health Ministry Clarifies: Ispire Licensed for Nicotine Manufacturing Only, Not for Local E-Cigarette Sales
Malaysia’s Health Ministry Clarifies: Ispire Licensed for Nicotine Manufacturing Only, Not for Local E-Cigarette Sales
Malaysia’s Health Ministry recently clarified that although foreign company Ispire has been granted a manufacturing license to produce nicotine-containing vaping devices, the license is for export purposes only and does not permit local sales. Under the 2024 Control of Smoking Products Act, all e-cigarette products must be registered with the Health Ministry before being sold in Malaysia.
Jun.05 by 2FIRSTS.ai